alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Akshay K. Vaishnaw M.D., Ph.D.
Chief Medical Officer and Executive Vice President of Research and Development, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 17 board members in 2 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Akshay K. Vaishnaw, MD, Ph.D., has been Chief Medical Officer of Alnylam Pharmaceuticals, Inc. since June 13, 2011 and has been its Executive Vice President of Research and Development since December 2014. Dr. Vaishnaw served as Executive Vice President of Alnylam Pharmaceuticals, Inc. June 2012 to December 2014. He served as Senior Vice President of Clinical Research at Alnylam Pharmaceuticals, Inc. from December 2008 to June 13, 2011 and served as its Senior Vice ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*
Harvard Business School
University Of London
University Of Wales College Of Medicine
University of Wales School of Medicine
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|